Fibroblast growth factor receptors in cancer: genetic alterations, diagnostics, therapeutic targets and mechanisms of resistance
Melanie A. Krook(The Ohio State University), Sameek Roychowdhury(The Ohio State University Wexner Medical Center), Julie W. Reeser(The Ohio State University), Max Wilberding(The Ohio State University), Gary Li(National Eczema Association), Gabrielle Ernst(The Ohio State University), Hui‐Zi Chen(Medical College of Wisconsin), Hannah Barker(The Ohio State University)
Cited by 357
Related Papers
Landscape of Microsatellite Instability Across 39 Cancer Types
|JCO Precision Oncology|2017|1.5k
Activating ESR1 mutations in hormone-resistant metastatic breast cancer
|Nature Genetics|2013|1.2k
Identification of recurrent NAB2-STAT6 gene fusions in solitary fibrous tumor by integrative sequencing
|Nature Genetics|2013|818
Identification of Targetable FGFR Gene Fusions in Diverse Cancers
|Cancer Discovery|2013|737
Personalized Oncology Through Integrative High-Throughput Sequencing: A Pilot Study
|Science Translational Medicine|2011|637